Top

Published in:

Open Access 16-09-2023 | Insulins | Review

Optimising Insulin Injection Techniques to Improve Diabetes Outcomes

Authors: Sanjay Kalra, Faruque Pathan, Ida Ayu Made Kshanti, Nguyen Quang Bay, Terumasa Nagase, Teresa Oliveria, Shailendra Bajpai

Published in: Diabetes Therapy | Issue 11/2023

Abstract

The effectiveness of therapy in patients with diabetes depends on the correct use of the insulin injection technique. However, despite many established recommendations and evidence that an effective insulin injection technique is essential to improve glycaemic control and minimise the risk associated with diabetes, there is still a need to identify impediments to the insulin injection technique among patients and create awareness among patients and healthcare professionals about the importance of the optimisation of insulin injection techniques. This review focuses on the recent advancements in delivery devices, insulin injection technique teaching methods, monitoring, and complication management and highlights regional best practices and recommendations for optimising injection techniques to improve diabetes outcomes.

International Diabetes Federation (IDF). IDF diabetes atlas 2021. Brussels: International Diabetes Federation; 2021.

Lepeska M. Insulin users’ perspective profile 2017. Amsterdam: Health Action International; 2017.

Bajwa SS, Bajwa S, Baruah M, Kalra S. An acute need for awareness of insulin injection guidelines in operative and intensive care units. Anesth Essays Res. 2013;7:1. https://doi.org/10.4103/0259-1162.113976.CrossRefPubMedPubMedCentral

Gibney MA, Fitz-Patrick D, Klonoff DC, Whooley S, Lu B, Yue W, et al. User experiences with second-generation 32-gauge × 4 mm vs thinner comparator pen needles: prospective randomized trial. Curr Med Res Opin. 2020;36:1591–600. https://doi.org/10.1080/03007995.2020.1803248.CrossRefPubMed

Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss K. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1:145–50. https://doi.org/10.1016/j.jcte.2014.07.006.CrossRefPubMedPubMedCentral

Frid AH, Hirsch LJ, Menchior AR, Morel DR, Strauss KW. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clin Proc. 2016;91:1212–23. https://doi.org/10.1016/j.mayocp.2016.06.011.CrossRefPubMed

Netere AK, Ashete E, Gebreyohannes EA, Belachew SA. Evaluations of knowledge, skills and practices of insulin storage and injection handling techniques of diabetic patients in Ethiopian primary hospitals. BMC Public Health. 2020;20:1537. https://doi.org/10.1186/s12889-020-09622-4.CrossRefPubMedPubMedCentral

Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas. Diabetes Ther. 2020;11:1251–69. https://doi.org/10.1007/s13300-020-00831-z.CrossRefPubMedPubMedCentral

Dickinson FS. Hypodermic syringe. US Patent US1742497, 1930.

10.

Whitney EH. Disposable Luer lock syringe. US Patent 4220151, 1980.

11.

Masierek M, Nabrdalik K, Janota O, Kwiendacz H, Macherski M, Gumprecht J. The review of insulin pens—past, present, and look to the future. Front Endocrinol. 2022;13:827484. https://doi.org/10.3389/fendo.2022.827484.CrossRef

12.

Tandon N, Kalra S, Balhara YS, Baruah M, Chadha M, Chandalia H, et al. Forum for injection technique and therapy expert recommendations, India: The Indian recommendations for best practice in insulin injection technique, 2017. Indian J Endocr Metab. 2017;21:600. https://doi.org/10.4103/ijem.IJEM_97_17.CrossRef

13.

Singh R, Samuel C, Jacob JJ. A comparison of insulin pen devices and disposable plastic syringes—simplicity, safety, convenience and cost differences. Eur Endocrinol. 2018;14:47. https://doi.org/10.17925/EE.2018.14.1.47.CrossRefPubMedPubMedCentral

14.

Kesavadev J, Saboo B, Benny N, Basanth A, Krishnan G, Shankar A, et al. One hundred and one years of insulin delivery with transition from syringes to user-friendly technologies. Int J Diabetes Technol 2022;1:25–31.

15.

Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013;35:923-933.e4. https://doi.org/10.1016/j.clinthera.2013.05.020.CrossRefPubMed

16.

Whooley S, Briskin T, Gibney MA, Blank LR, Berube J, Pflug BK. Evaluating the user performance and experience with a re-engineered 4 mm × 32g pen needle: a randomized trial with similar length/gauge needles. Diabetes Ther. 2019;10:697–712. https://doi.org/10.1007/s13300-019-0585-7.CrossRefPubMedPubMedCentral

17.

Heinemann L, Nguyen T, Bailey TS, Hassoun A, Kulzer B, Oliveria T, et al. Needle technology for insulin administration: a century of innovation. J Diabetes Sci Technol. 2021. https://doi.org/10.1177/19322968211059564.CrossRefPubMedPubMedCentral

18.

American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment. Diabetes Care 2021;40:S64–74. https://doi.org/10.2337/dc17-S011.

19.

Hirsch LJ, Gibney MA, Li L, Bérubé J. Glycemic control, reported pain and leakage with a 4 mm × 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis. Curr Med Res Opin. 2012;28:1305–11. https://doi.org/10.1185/03007995.2012.709181.CrossRefPubMed

20.

Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, et al. New injection recommendations for patients with diabetes. Diabetes Metab. 2010. https://doi.org/10.1016/S1262-3636(10)70002-1.CrossRefPubMed

21.

Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91:1231–55. https://doi.org/10.1016/j.mayocp.2016.06.010.CrossRefPubMed

22.

Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26:1519–30. https://doi.org/10.1185/03007995.2010.481203.CrossRefPubMed

23.

Rini C, Roberts BC, Morel D, Klug R, Selvage B, Pettis RJ. Evaluating the impact of human factors and pen needle design on insulin pen injection. J Diabetes Sci Technol. 2019;13:533–45. https://doi.org/10.1177/1932296819836987.CrossRefPubMedPubMedCentral

24.

Selvadurai S, Cheah KY, Ching MW, Kamaruddin H, Lee XY, Ngajidin RM, et al. Impact of pharmacist insulin injection re-education on glycemic control among type II diabetic patients in primary health clinics. Saudi Pharm J. 2021;29:670–6. https://doi.org/10.1016/j.jsps.2021.04.028.CrossRefPubMedPubMedCentral

25.

Liang K, Xie Q, Nie J, Deng J. Study on the effect of education for insulin injection in diabetic patients with new simulation tools. Medicine. 2021;100: e25424. https://doi.org/10.1097/MD.0000000000025424.CrossRefPubMedPubMedCentral

26.

Misnikova IV, Gubkina VA, Lakeeva TS, Dreval AV. A randomized controlled trial to assess the impact of proper insulin injection technique training on glycemic control. Diabetes Ther. 2017;8:1309–18. https://doi.org/10.1007/s13300-017-0315-y.

27.

Pledger J, Hicks D, Kirkland F, Down S. Importance of injection technique in diabetes. Diabetes Prim Care. 2012;14:6.

28.

De Coninck C, Frid A, Gaspar R, Hicks D, Hirsch L, Kreugel G, et al. Results and analysis of the 2008–2009 insulin injection technique questionnaire survey: insulin injection technique survey. J Diabetes. 2010;2:168–79. https://doi.org/10.1111/j.1753-0407.2010.00077.x.CrossRefPubMed

29.

FIT. Forum for Injection Technique. 2022. http://www.fit4diabetes.com/. Accessed 7 June 2022.

30.

Nakatani Y, Matsumura M, Monden T, Aso Y, Nakamoto T. Improvement of glycemic control by re-education in insulin injection technique in patients with diabetes mellitus. Adv Ther. 2013;30:897–906. https://doi.org/10.1007/s12325-013-0066-8.CrossRefPubMed

31.

Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M, et al. The durability of an intensive, structured education-based rehabilitation protocol for best insulin injection practice: the ISTERP-2 study. Diabetes Ther. 2021;12:2557–69. https://doi.org/10.1007/s13300-021-01108-9.CrossRefPubMedPubMedCentral

32.

Chen L, Xing Q, Li J, Zhou J, Yuan Y, Wan Y, et al. Injection technique education in patients with diabetes injecting insulin into areas of lipohypertrophy: a randomized controlled trial. Diabetes Ther. 2021;12:813–26. https://doi.org/10.1007/s13300-021-01013-1.CrossRefPubMedPubMedCentral

33.

Ucieklak D, Mrozinska S, Wojnarska A, Malecki MT, Klupa T, Matejko B. Insulin-induced lipohypertrophy in patients with type 1 diabetes mellitus treated with an insulin pump. Int J Endocrinol. 2022;2022:1–7. https://doi.org/10.1155/2022/9169296.CrossRef

34.

Deng N, Zhang X, Zhao F, Wang Y, He H. Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis. J Diabetes Investig. 2018;9:536–43. https://doi.org/10.1111/jdi.12742.CrossRef

35.

Gentile S, Strollo F, Guarino G, Brancario C, Corigliano M, Cozzolino G, et al. Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest? Diabetes Metab Syndr. 2019;13:682–6. https://doi.org/10.1016/j.dsx.2018.11.042.CrossRefPubMed

36.

Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Insulin-related lipohypertrophy: lipogenic action or tissue trauma? Front Endocrinol. 2018;9:638. https://doi.org/10.3389/fendo.2018.00638.

37.

Nilsson MR. Insulin amyloid at injection sites of patients with diabetes. Amyloid. 2016;23:139–47. https://doi.org/10.1080/13506129.2016.1179183.CrossRefPubMed

38.

Ansari AM, Osmani L, Matsangos AE, Li QK. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis. Pathol Res Practice. 2017;213:1237–41. https://doi.org/10.1016/j.prp.2017.08.013.CrossRef

39.

Nagase T, Iwaya K, Iwaki Y, Kotake F, Uchida R, Oh-i T, et al. Insulin-derived amyloidosis and poor glycemic control: a case series. Am J Med. 2014;127:450–4. https://doi.org/10.1016/j.amjmed.2013.10.029.CrossRefPubMed

40.

Nagase T, Iwaya K, Kogure K, Zako T, Misumi Y, Kikuchi M, et al. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: a report of two cases. J Diabetes Investig. 2020;11:1002–5. https://doi.org/10.1111/jdi.13199.CrossRefPubMedPubMedCentral

41.

Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F, AMD-OSDI Italian Injection Technique Study Group. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. SpringerPlus. 2016;5:563. https://doi.org/10.1186/s40064-016-1978-y.CrossRefPubMedPubMedCentral

42.

Korkmaz FN, Gökçay Canpolat A, Güllü S. Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes. Endocrinol Diabetes Nutr (English Ed). 2022;69:354–61. https://doi.org/10.1016/j.endien.2022.05.006.

43.

Wang W, Tong Y, Chen Y, Tu M, Chen H. Evaluation of ultrasound examination combined with intensive injection technique education on insulin-induced lipohypertrophy (LH) management: a prospective cohort study in China. Int J Diabetes Dev Ctries. 2021;41:669–75. https://doi.org/10.1007/s13410-021-00935-7.CrossRef

44.

IQVIA. Optimizing insulin use through smart pens: challenges and opportunities in Europe. Durham, NC: IQVIA; 2021.

45.

Sy SL, Munshi MM, Toschi E. Can smart pens help improve diabetes management? J Diabetes Sci Technol. 2020. https://doi.org/10.1177/1932296820965600.CrossRefPubMedPubMedCentral

46.

Kalra S, Kumar A, Gupta Y. Prevention of lipohypertrophy. J Pak Med Assoc. 2016;66(7):910–1.PubMed

47.

Kalra S, Sahay R, Tiwaskar M. Need for insulin stewardship programmes. J Assoc Physicians India. 2018;66:83–4.PubMed

48.

Kalra S, Unnikrishnan AG, Prasanna Kumar KM, Sahay R, Chandalia HB, Saboo B, et al. Addendum 1: forum for injection technique and therapy expert recommendations, India. Diabetes Ther. 2022. https://doi.org/10.1007/s13300-022-01332-x.CrossRefPubMedPubMedCentral

49.

Spollett G, Edelman SV, Mehner P, Walter C, Penfornis A. Improvement of insulin injection technique: examination of current issues and recommendations. Diabetes Educ. 2016;42:379–94. https://doi.org/10.1177/0145721716648017.CrossRefPubMed

50.

Strauss K. Best practice diabetes injection technique is key to improved glycaemic variability and avoiding injection site issues. General Med. 2014. https://doi.org/10.4172/2327-5146.1000168.CrossRef

51.

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, et al. Indian injection technique study: injecting complications, education, and the health care professional. Diabetes Ther. 2017;8:659–72. https://doi.org/10.1007/s13300-017-0244-9.CrossRefPubMedPubMedCentral

52.

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, et al. Indian injection technique study: population characteristics and injection practices. Diabetes Ther. 2017;8:637–57. https://doi.org/10.1007/s13300-017-0243-x.CrossRefPubMedPubMedCentral

Title: Optimising Insulin Injection Techniques to Improve Diabetes Outcomes
Authors: Sanjay Kalra
Faruque Pathan
Ida Ayu Made Kshanti
Nguyen Quang Bay
Terumasa Nagase
Teresa Oliveria
Shailendra Bajpai
Publication date: 16-09-2023
Publisher: Springer Healthcare
Keywords: Insulins
Insulins
Published in: Diabetes Therapy / Issue 11/2023
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI: https://doi.org/10.1007/s13300-023-01460-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2023

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide

Correction to: Prevalence of Diabetic Kidney Disease with Different Subtypes in Hospitalized Patients with Diabetes and Correlation Between eGFR and LncRNA XIST Expression in PBMCs

Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations

Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials